These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 39459319)

  • 1. The Role of Peptides in Combatting HIV Infection: Applications and Insights.
    Helmy NM; Parang K
    Molecules; 2024 Oct; 29(20):. PubMed ID: 39459319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HBV polymerase-derived peptide exerts an anti-HIV-1 effect by inhibiting the acetylation of viral integrase.
    Kim H; Lee SY; Choi YM; Kim BJ
    Biochem Biophys Res Commun; 2018 Jun; 501(2):541-546. PubMed ID: 29752938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An effective conjugation strategy for designing short peptide-based HIV-1 fusion inhibitors.
    Liang G; Wang H; Chong H; Cheng S; Jiang X; He Y; Wang C; Liu K
    Org Biomol Chem; 2016 Aug; 14(33):7875-82. PubMed ID: 27454320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptides as new inhibitors of HIV-1 reverse transcriptase and integrase.
    de Soultrait VR; Desjobert C; Tarrago-Litvak L
    Curr Med Chem; 2003 Sep; 10(18):1765-78. PubMed ID: 12871103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides.
    Secchi M; Longhi R; Vassena L; Sironi F; Grzesiek S; Lusso P; Vangelista L
    Chem Biol; 2012 Dec; 19(12):1579-88. PubMed ID: 23261601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs.
    Marra M; Catalano A; Sinicropi MS; Ceramella J; Iacopetta D; Salpini R; Svicher V; Marsico S; Aquaro S; Pellegrino M
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide inhibition of HIV-1: current status and future potential.
    Kaushik-Basu N; Basu A; Harris D
    BioDrugs; 2008; 22(3):161-75. PubMed ID: 18481899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of HIV infection as the key to eradication? New therapeutic approaches].
    Manegold C
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():34-9. PubMed ID: 10863308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The current progress in the development of HIV-1 fusion inhibitors].
    Shi WG; Jia QY; Liu KL
    Yao Xue Xue Bao; 2010 Feb; 45(2):184-93. PubMed ID: 21351428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.
    Shimane K; Kodama EN; Nakase I; Futaki S; Sakurai Y; Sakagami Y; Li X; Hattori T; Sarafianos SG; Matsuoka M
    Int J Biochem Cell Biol; 2010 Sep; 42(9):1482-8. PubMed ID: 20580677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies towards HIV-1 infection in macrophages.
    Perno CF; Svicher V; Schols D; Pollicita M; Balzarini J; Aquaro S
    Antiviral Res; 2006 Sep; 71(2-3):293-300. PubMed ID: 16806514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of peptide motifs against HIV-1 reverse transcriptase and integrase.
    Andréola ML
    Curr Pharm Des; 2009; 15(21):2508-19. PubMed ID: 19601847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors.
    Spearman P
    Curr Top Med Chem; 2016; 16(10):1154-66. PubMed ID: 26329615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-Based HIV Entry Inhibitors.
    Pu J; Wang Q; Jiang S
    Adv Exp Med Biol; 2022; 1366():15-26. PubMed ID: 35412132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyproline-containing collagen peptide derived from the skin of the Alaska pollack inhibits HIV-1 infection.
    Jang IS; Park SJ
    Mol Med Rep; 2016 Dec; 14(6):5489-5494. PubMed ID: 27878297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 drug discovery: targeting folded RNA structures with branched peptides.
    Wynn JE; Santos WL
    Org Biomol Chem; 2015 Jun; 13(21):5848-58. PubMed ID: 25958855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV chemotherapy.
    Richman DD
    Nature; 2001 Apr; 410(6831):995-1001. PubMed ID: 11309630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV co-receptors as targets for antiviral therapy.
    Schols D
    Curr Top Med Chem; 2004; 4(9):883-93. PubMed ID: 15134547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to win the HIV-1 drug resistance hurdle race: running faster or jumping higher?
    Garbelli A; Riva V; Crespan E; Maga G
    Biochem J; 2017 Apr; 474(10):1559-1577. PubMed ID: 28446620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral breadth and combination potential of peptide triazole HIV-1 entry inhibitors.
    McFadden K; Fletcher P; Rossi F; Kantharaju ; Umashankara M; Pirrone V; Rajagopal S; Gopi H; Krebs FC; Martin-Garcia J; Shattock RJ; Chaiken I
    Antimicrob Agents Chemother; 2012 Feb; 56(2):1073-80. PubMed ID: 22083481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.